Cambridge Investment Research Advisors
WVE icon

Cambridge Investment Research Advisors’s Wave Life Sciences WVE Stock Holding History

Cambridge Investment Research Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,000
Closed -$78K – 3280
2021
Q3 		$78K Hold
16,000
– – ﹤0.01% 2990
2021
Q2 		$107K Buy
+16,000
New +$105K ﹤0.01% 2962

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cambridge Investment Research Advisors's WVE Position: Q4 2021 in Review

Cambridge Investment Research Advisors sold out of Wave Life Sciences (WVE) in Q4 2021, closing a stake of 16,000 shares — an estimated $78K sold.

Cambridge Investment Research Advisors first reported a position in WVE in Q2 2021 and held it in 2 quarters. The position peaked at $107K in Q2 2021. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2021.

  • Cambridge Investment Research Advisors reported no remaining Wave Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 16,000 Wave Life Sciences shares in Q4 2021, an estimated $78K.
  • Cambridge Investment Research Advisors first reported a position in Wave Life Sciences in Q2 2021 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Wave Life Sciences position peaked at $107K in Q2 2021.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.